Titre :
  • A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
Auteur : Demotte, Nathalie ; Wieërs, Grégoire ; Van Der Smissen, Patrick ; Moser, Muriel ; Schmidt, Christopher ; Thielemans, Kris M. ; Squifflet, Jean-Luc ; Weynand, Birgit ; Carrasco, Javier ; Lurquin, Christophe ; Courtoy, Pierre ; van der Bruggen, Pierre
Informations sur la publication : Cancer research, 70, 19, (page 7476-7488)
Statut de publication : Publié, 2010-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Amino Sugars -- pharmacology
Animals
Ascites -- immunology -- pathology
Breast Neoplasms -- immunology -- pathology -- therapy
CD4-Positive T-Lymphocytes -- drug effects -- immunology
CD8-Positive T-Lymphocytes -- drug effects -- immunology
Cancer Vaccines -- immunology -- pharmacology
Cell Line, Tumor
Female
Galectin 3 -- immunology
Humans
Interferon-gamma -- immunology -- secretion
Ligands
Lymphocytes, Tumor-Infiltrating -- drug effects -- immunology
Mastocytoma -- drug therapy -- immunology
Melanoma -- immunology -- pathology -- therapy
Mice
Neoplasms -- drug therapy -- immunology -- therapy
Pleural Effusion, Malignant -- immunology -- pathology
Polysaccharides -- pharmacology
Receptors, Antigen, T-Cell -- immunology
Note : Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0008-5472 
info:doi/10.1158/0008-5472.CAN-10-0761
info:pii/0008-5472.CAN-10-0761
info:pmid/20719885